Patten & Patten’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.38M | Sell |
57,400
-1,858
| -3% | -$48.6K | 0.07% | 156 |
|
|
2026
Q1 | $1.66M | Buy |
59,258
+1,577
| +3% | +$42K | 0.1% | 141 |
|
|
2025
Q4 | $1.44M | Sell |
57,681
-2,953
| -5% | -$74.5K | 0.08% | 155 |
|
|
2025
Q3 | $1.54M | Sell |
60,634
-3,459
| -5% | -$85.4K | 0.09% | 151 |
|
|
2025
Q2 | $1.55M | Sell |
64,093
-15,780
| -20% | -$368K | 0.1% | 142 |
|
|
2025
Q1 | $2.02M | Sell |
79,873
-1,121
| -1% | -$29.3K | 0.14% | 111 |
|
|
2024
Q4 | $2.15M | Sell |
80,994
-8,188
| -9% | -$222K | 0.14% | 107 |
|
|
2024
Q3 | $2.58M | Buy |
89,182
+10,955
| +14% | +$320K | 0.17% | 100 |
|
|
2024
Q2 | $2.19M | Buy |
78,227
+7,309
| +10% | +$201K | 0.15% | 109 |
|
|
2024
Q1 | $1.97M | Sell |
70,918
-13,437
| -16% | -$373K | 0.14% | 119 |
|
|
2023
Q4 | $2.43M | Sell |
84,355
-9,709
| -10% | -$294K | 0.2% | 92 |
|
|
2023
Q3 | $3.12M | Sell |
94,064
-1,678
| -2% | -$59.3K | 0.27% | 76 |
|
|
2023
Q2 | $3.51M | Buy |
95,742
+3,408
| +4% | +$133K | 0.29% | 76 |
|
|
2023
Q1 | $3.77M | Sell |
92,334
-5,186
| -5% | -$224K | 0.33% | 69 |
|
|
2022
Q4 | $5M | Sell |
97,520
-3,558
| -4% | -$171K | 0.45% | 61 |
|
|
2022
Q3 | $4.42M | Buy |
101,078
+235
| +0.2% | +$11.4K | 0.42% | 66 |
|
|
2022
Q2 | $5.29M | Sell |
100,843
-672
| -0.7% | -$34.2K | 0.46% | 61 |
|
|
2022
Q1 | $5.25M | Sell |
101,515
-279
| -0.3% | -$14.5K | 0.38% | 73 |
|
|
2021
Q4 | $6.01M | Buy |
101,794
+2,981
| +3% | +$148K | 0.42% | 71 |
|
|
2021
Q3 | $4.25M | Sell |
98,813
-347
| -0.3% | -$15.4K | 0.32% | 77 |
|
|
2021
Q2 | $3.88M | Sell |
99,160
-1,428
| -1% | -$55.5K | 0.3% | 77 |
|
|
2021
Q1 | $3.64M | Sell |
100,588
-8,575
| -8% | -$304K | 0.3% | 77 |
|
|
2020
Q4 | $4.02M | Sell |
109,163
-2,455
| -2% | -$90K | 0.35% | 70 |
|
|
2020
Q3 | $3.89M | Buy |
111,618
+3,086
| +3% | +$108K | 0.39% | 67 |
|
|
2020
Q2 | $3.37M | Buy |
108,532
+1,706
| +2% | +$58K | 0.37% | 69 |
|
|
2020
Q1 | $3.31M | Sell |
106,826
-11,832
| -10% | -$403K | 0.44% | 60 |
|
|
2019
Q4 | $4.41M | Sell |
118,658
-12,465
| -10% | -$444K | 0.44% | 56 |
|
|
2019
Q3 | $4.47M | Sell |
131,123
-6,359
| -5% | -$231K | 0.49% | 56 |
|
|
2019
Q2 | $5.65M | Sell |
137,482
-2,306
| -2% | -$91.6K | 0.61% | 53 |
|
|
2019
Q1 | $5.63M | Buy |
139,788
+69
| +0% | +$2.76K | 0.62% | 55 |
|
|
2018
Q4 | $5.79M | Sell |
139,719
-1,008
| -0.7% | -$41.8K | 0.71% | 53 |
|
|
2018
Q3 | $5.88M | Sell |
140,727
-3,446
| -2% | -$133K | 0.58% | 54 |
|
|
2018
Q2 | $4.96M | Sell |
144,173
-11,228
| -7% | -$384K | 0.51% | 55 |
|
|
2018
Q1 | $5.23M | Sell |
155,401
-2,502
| -2% | -$86K | 0.53% | 57 |
|
|
2017
Q4 | $5.43M | Sell |
157,903
-6,379
| -4% | -$218K | 0.54% | 58 |
|
|
2017
Q3 | $5.56M | Sell |
164,282
-10,129
| -6% | -$326K | 0.59% | 58 |
|
|
2017
Q2 | $5.56M | Sell |
174,411
-25,894
| -13% | -$817K | 0.61% | 54 |
|
|
2017
Q1 | $6.5M | Sell |
200,305
-4,517
| -2% | -$142K | 0.75% | 45 |
|
|
2016
Q4 | $6.31M | Sell |
204,822
-8,121
| -4% | -$248K | 0.78% | 42 |
|
|
2016
Q3 | $6.84M | Sell |
212,943
-2,631
| -1% | -$88K | 0.88% | 36 |
|
|
2016
Q2 | $7.2M | Buy |
215,574
+5,261
| +3% | +$168K | 1% | 35 |
|
|
2016
Q1 | $5.91M | Buy |
210,313
+5,215
| +3% | +$149K | 0.85% | 39 |
|
|
2015
Q4 | $6.28M | Sell |
205,098
-919
| -0.4% | -$28.9K | 0.87% | 40 |
|
|
2015
Q3 | $6.14M | Sell |
206,017
-1,685
| -0.8% | -$54K | 0.94% | 41 |
|
|
2015
Q2 | $6.61M | Sell |
207,702
-2,152
| -1% | -$70.1K | 0.96% | 39 |
|
|
2015
Q1 | $6.93M | Buy |
209,854
+1,521
| +0.7% | +$48.4K | 1% | 38 |
|
|
2014
Q4 | $6.16M | Buy |
208,333
+5,400
| +3% | +$155K | 0.93% | 42 |
|
|
2014
Q3 | $5.69M | Buy |
202,933
+4,951
| +3% | +$139K | 0.91% | 42 |
|
|
2014
Q2 | $5.58M | Sell |
197,982
-4,497
| -2% | -$128K | 0.91% | 42 |
|
|
2014
Q1 | $6.17M | Buy |
202,479
+15,122
| +8% | +$451K | 0.84% | 46 |
|
|
2013
Q4 | $5.45M | Buy |
187,357
+1,556
| +0.8% | +$45.3K | 0.76% | 48 |
|
|
2013
Q3 | $5.06M | Buy |
185,801
+12,230
| +7% | +$333K | 0.79% | 49 |
|
|
2013
Q2 | $4.61M | Buy |
+173,571
| New | +$4.8M | 0.76% | 45 |
|
Other funds holding PFE
Patten & Patten's PFE Position: Q2 2026 in Review
Patten & Patten reduced its Pfizer (PFE) stake by 3.1% in Q2 2026, selling an estimated $48.6K and leaving 57,400 shares worth $1.38M. The position accounts for 0.07% of the portfolio, ranked #156.
Patten & Patten first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.2M in Q2 2016. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Patten & Patten held 57,400 shares of Pfizer worth $1.38M as of Q2 2026.
- Patten & Patten sold 1,858 Pfizer shares in Q2 2026, an estimated $48.6K.
- Pfizer made up 0.07% of Patten & Patten's portfolio in Q2 2026, its #156 holding.
- Patten & Patten first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Patten & Patten's Pfizer position peaked at $7.2M in Q2 2016.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Patten & Patten's 13F filing for Q2 2026, filed 5 Aug 2026.